Search

everythinglearnresearchcommunity

for

Search:↓

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Prolactin slows down hair growth in mice.

Some medications can cause acne, and stopping these drugs is the main treatment.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

New alopecia treatments aim for better results and fewer side effects.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

LED light therapy may help hair growth by activating certain cell pathways.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

RADA16 is a promising material for tissue repair and regenerative medicine but needs improvement in strength and cost.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Immune cells affect hair growth and could lead to new hair loss treatments.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some drugs used to treat inflammation may cause hair loss.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.